2016 March 2, “A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus”, in PLOS ONE[1], →DOI:
N, number of patients in cohort; n, number of patients with nonmissing values; NA, not applicable.